Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004
Provided By GlobeNewswire
Last update: Feb 13, 2024
-- Activation of four U.S. sites for Phase 1 clinical trial of PAS-004 to evaluate safety, dose, key biomarker data and preliminary efficacy --
-- Plans to open three additional sites in Eastern Europe in the coming months --
Read more at globenewswire.com0.96
-0.17 (-15.04%)
NASDAQ:KTTAW (5/7/2025, 8:16:31 PM)
0.022
-0.01 (-23.08%)
Find more stocks in the Stock Screener
KTTA Latest News and Analysis
a day ago - ChartmillWednesday's session: top gainers and losersKeep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.
2 days ago - ChartmillWhich stocks are most active on Tuesday?Let's have a look at what is happening on the US markets on Tuesday. Below you can find the most active stocks in today's session.
2 days ago - ChartmillWhat's going on in today's pre-market sessionWondering what's happening in Tuesday's pre-market session? Find an overview in this article.
